TY - JOUR
T1 - Lifestyle and genetic risk of chronic liver disease in metabolically healthy and unhealthy individuals from the general population
AU - Senior Partnerships & Business Operations
AU - Business Operations & Administrative Coordinators
AU - RGC Management & Leadership Team
AU - Sequencing & Lab Operations
AU - Clinical Informatics
AU - Genome Informatics & Data Engineering
AU - Analytical Genetics and Data Science
AU - Therapeutic Area Genetics
AU - Research Program Management & Strategic Initiatives
AU - Drake, Isabel
AU - Giontella, Alice
AU - Miari, Mariam
AU - Önnerhag, Kristina
AU - Orho-Melander, Marju
AU - Abecasis, Gonçalo
AU - Ferrando, Adolfo
AU - Baras, Aris
AU - Cantor, Michael
AU - Coppola, Giovanni
AU - Deubler, Andrew
AU - Economides, Aris
AU - Lotta, Luca A.
AU - Overton, John D.
AU - Reid, Jeffrey G.
AU - Shuldiner, Alan
AU - Siminovitch, Katherine
AU - Beechert, Christina
AU - Brian, Erin D.
AU - Cremona, Laura M.
AU - Du, Hang
AU - Forsythe, Caitlin
AU - Gu, Zhenhua
AU - Guevara, Kristy
AU - Lattari, Michael
AU - Lopez, Alexander
AU - Manoochehri, Kia
AU - Challa, Prathyusha
AU - Pradhan, Manasi
AU - Reynoso, Raymond
AU - Schiavo, Ricardo
AU - Padilla, Maria Sotiropoulos
AU - Wang, Chenggu
AU - Wolf, Sarah E.
AU - Averitt, Amelia
AU - Banerjee, Nilanjana
AU - Li, Dadong
AU - Malhotra, Sameer
AU - Mower, Justin
AU - Sarwar, Mudasar
AU - Sharma, Deepika
AU - Staples, Jeffrey C.
AU - Yu, Sean
AU - Zhang, Aaron
AU - Nafde, Mona
AU - Mitra, George
AU - Gokhale, Sujit
AU - Bunyea, Andrew
AU - Vrieze, Scott
AU - Otto, Jacqueline
N1 - Publisher Copyright:
© 2024 The Author(s)
PY - 2024/8
Y1 - 2024/8
N2 - Background & Aims: It is unclear to what extent lifestyle and genetic factors affect the incidence of chronic liver disease (CLD) in the general population and if lifestyle affects CLD independently of underlying cardiometabolic perturbations and genetic predisposition. Methods: We examined 27,991 men and women aged 44-73 years from the Malmö Diet and Cancer Study recruited between 1991-1996 and followed until the end of 2020 using registry linkage (median follow-up time 25.1 years; 382 incident first-time CLD events). Associations between cardiometabolic factors, polygenic risk scores (PRSs), and lifestyle factors in relation to CLD were examined using multivariable Cox proportional hazards regression models. Results: The incidence of CLD increased with number of cardiometabolic risk factors (the hazard ratio per each additional cardiometabolic risk factor was 1.33; 95% CI 1.21-1.45; p = 5.1 x 10-10). Two novel PRSs for metabolic dysfunction-associated steatotic liver disease and a PRS for cirrhosis were associated with higher risk of CLD but provided marginal predictive utility on top of other risk factors and compared to the PNPLA3 rs738409 genetic variant. An unhealthy lifestyle (high alcohol intake, current smoking, physical inactivity and unhealthy diet) markedly increased the risk of CLD (hazard ratio 3.97, 95% CI 2.59-6.10). Observed associations between examined lifestyle factors and CLD were largely independent of cardiometabolic perturbations and polygenic risk. Conclusions: We confirmed the importance of cardiometabolic dysfunction in relation to risk of CLD in the general population. Lifestyle risk factors were shown to be independently associated with CLD and added predictive information on top of cardiometabolic risk factors. Information on the polygenic risk of liver disease does not currently improve the prediction of CLD in the general population. Impact and implications: This large population-based prospective study suggests largely independent roles of cardiometabolic, lifestyle, and genetic risk factors in the development of chronic liver disease. Findings strengthen the evidence base for a beneficial effect of modification of high-risk lifestyle behaviors in the primary prevention of chronic liver disease in the general population.
AB - Background & Aims: It is unclear to what extent lifestyle and genetic factors affect the incidence of chronic liver disease (CLD) in the general population and if lifestyle affects CLD independently of underlying cardiometabolic perturbations and genetic predisposition. Methods: We examined 27,991 men and women aged 44-73 years from the Malmö Diet and Cancer Study recruited between 1991-1996 and followed until the end of 2020 using registry linkage (median follow-up time 25.1 years; 382 incident first-time CLD events). Associations between cardiometabolic factors, polygenic risk scores (PRSs), and lifestyle factors in relation to CLD were examined using multivariable Cox proportional hazards regression models. Results: The incidence of CLD increased with number of cardiometabolic risk factors (the hazard ratio per each additional cardiometabolic risk factor was 1.33; 95% CI 1.21-1.45; p = 5.1 x 10-10). Two novel PRSs for metabolic dysfunction-associated steatotic liver disease and a PRS for cirrhosis were associated with higher risk of CLD but provided marginal predictive utility on top of other risk factors and compared to the PNPLA3 rs738409 genetic variant. An unhealthy lifestyle (high alcohol intake, current smoking, physical inactivity and unhealthy diet) markedly increased the risk of CLD (hazard ratio 3.97, 95% CI 2.59-6.10). Observed associations between examined lifestyle factors and CLD were largely independent of cardiometabolic perturbations and polygenic risk. Conclusions: We confirmed the importance of cardiometabolic dysfunction in relation to risk of CLD in the general population. Lifestyle risk factors were shown to be independently associated with CLD and added predictive information on top of cardiometabolic risk factors. Information on the polygenic risk of liver disease does not currently improve the prediction of CLD in the general population. Impact and implications: This large population-based prospective study suggests largely independent roles of cardiometabolic, lifestyle, and genetic risk factors in the development of chronic liver disease. Findings strengthen the evidence base for a beneficial effect of modification of high-risk lifestyle behaviors in the primary prevention of chronic liver disease in the general population.
KW - chronic liver disease
KW - cirrhosis
KW - diet
KW - lifestyle
KW - metabolic dysfunction-associated steatotic liver disease
KW - polygenic risk
UR - https://www.scopus.com/pages/publications/85197039487
UR - https://www.scopus.com/pages/publications/85197039487#tab=citedBy
U2 - 10.1016/j.jhepr.2024.101105
DO - 10.1016/j.jhepr.2024.101105
M3 - Article
C2 - 39049959
AN - SCOPUS:85197039487
SN - 2589-5559
VL - 6
JO - JHEP Reports
JF - JHEP Reports
IS - 8
M1 - 101105
ER -